Chemical changes to peptide siRNA-carrier enhance gene silencing for future cancer drugs

Researchers found a modified peptide carrier that was delivering the siRNA drug by adhering to and potentially moving along cell filopodia, leading to more efficient cell entry and improved gene silencing.